These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26073672)

  • 1. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study.
    Ziegler R; Rees C; Jacobs N; Parkin CG; Lyden MR; Petersen B; Wagner RS
    Pediatr Diabetes; 2016 Aug; 17(5):311-8. PubMed ID: 26073672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
    Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
    Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
    Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
    Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
    Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.
    Barnard K; Parkin C; Young A; Ashraf M
    J Diabetes Sci Technol; 2012 Jan; 6(1):144-9. PubMed ID: 22401332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.
    van Meijel LA; van den Heuvel-Bens SP; Zimmerman LJ; Bazelmans E; Tack CJ; de Galan BE
    Clin Ther; 2018 Jun; 40(6):862-871. PubMed ID: 29502804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to Insulin Pump Behaviors in Young Children With Type 1 Diabetes Mellitus.
    Patton SR; Driscoll KA; Clements MA
    J Diabetes Sci Technol; 2017 Jan; 11(1):87-91. PubMed ID: 27390223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin-A Crossover Study.
    Gonzalez C; Picón MJ; Tomé M; Pujol I; Fernández-García JC; Chico A
    Diabetes Technol Ther; 2016 May; 18(5):282-7. PubMed ID: 26886163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in glycemic control through changes in insulin regimens: findings from a Japanese cohort of children and adolescents with type 1 diabetes.
    Mochizuki M; Kikuchi T; Urakami T; Kikuchi N; Kawamura T; Yokomichi H; Hoshino T; Matsuura N; Sasaki N; Sugihara S; Amemiya S;
    Pediatr Diabetes; 2017 Sep; 18(6):435-442. PubMed ID: 27460670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446].
    Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Wagner RS
    BMC Fam Pract; 2012 Oct; 13():102. PubMed ID: 23062116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
    Piechowiak K; Dżygało K; Szypowska A
    Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe and Efficacious Use of Automated Bolus Advisors in Individuals Treated With Multiple Daily Insulin Injection (MDI) Therapy: Lessons Learned From the Automated Bolus Advisor Control and Usability Study (ABACUS).
    Parkin CG; Barnard K; Hinnen DA
    J Diabetes Sci Technol; 2015 Mar; 9(5):1138-42. PubMed ID: 25795641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes.
    Leelarathna L; Roberts SA; Hindle A; Markakis K; Alam T; Chapman A; Morris J; Urwin A; Jinadev P; Rutter MK
    Diabet Med; 2017 Oct; 34(10):1372-1379. PubMed ID: 28636773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mealtime insulin bolus adherence and glycemic control in adolescents on insulin pump therapy.
    Spaans E; van Hateren KJJ; Groenier KH; Bilo HJG; Kleefstra N; Brand PLP
    Eur J Pediatr; 2018 Dec; 177(12):1831-1836. PubMed ID: 30238153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-Month Effectiveness of Advanced
    Tornese G; Buzzurro F; Carletti C; Faleschini E; Barbi E
    Front Endocrinol (Lausanne); 2021; 12():766314. PubMed ID: 34858339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.
    Cavan DA; Ziegler R; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Technol Ther; 2014 May; 16(5):310-6. PubMed ID: 24716820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.